GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and ...

In May 2025, the FDA approved mepolizumab (Nucala) as a treatment for chronic obstructive pulmonary disease (COPD). Before any drug gets near a pharmacy shelf, it starts with years of basic science ...

WAYNETOWN, Ind. — Tony Manion doesn't miss a workout. Seriously. Three hours a day, every day. "You just make a choice to do it," Manion said, between reps from his home gym in rural Montgomery County ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary ...

Recent medical research is reshaping our understanding of Chronic Obstructive Pulmonary Disease (COPD), particularly highlighting its disproportionate impact on women. This shift in the COPD landscape ...

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study. The study is ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...